X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1411) 1411
idazoxan (1143) 1143
male (1084) 1084
rats (928) 928
adrenergic alpha-antagonists - pharmacology (809) 809
dioxanes - pharmacology (646) 646
pharmacology & pharmacy (602) 602
idazoxan - pharmacology (488) 488
neurosciences (326) 326
rats, sprague-dawley (312) 312
female (311) 311
clonidine - pharmacology (307) 307
adrenergic alpha-agonists - pharmacology (298) 298
dose-response relationship, drug (267) 267
imidazoles - pharmacology (258) 258
yohimbine - pharmacology (256) 256
clonidine (255) 255
imidazoline receptors (255) 255
in vitro techniques (248) 248
rats, inbred strains (247) 247
idazoxan - analogs & derivatives (243) 243
humans (237) 237
prazosin - pharmacology (223) 223
norepinephrine - metabolism (192) 192
mice (168) 168
receptors, adrenergic, alpha - drug effects (167) 167
blood pressure - drug effects (163) 163
rats, wistar (162) 162
electric stimulation (159) 159
receptors, adrenergic, alpha-2 - metabolism (150) 150
rat (148) 148
noradrenaline (147) 147
dioxanes - metabolism (145) 145
receptors, adrenergic, alpha - physiology (143) 143
receptors, drug - metabolism (134) 134
norepinephrine - pharmacology (132) 132
adrenergic alpha-2 receptor antagonists (131) 131
adrenoceptors (128) 128
receptors (128) 128
rat-brain (127) 127
yohimbine (127) 127
brimonidine tartrate (126) 126
rabbits (126) 126
index medicus (122) 122
adrenergic alpha-antagonists - metabolism (119) 119
brain (119) 119
biochemistry & molecular biology (116) 116
quinoxalines - pharmacology (116) 116
heart rate - drug effects (114) 114
norepinephrine (114) 114
binding sites (110) 110
binding, competitive (109) 109
brain - metabolism (108) 108
receptors, adrenergic, alpha-2 - drug effects (107) 107
receptors, adrenergic, alpha - metabolism (106) 106
binding-sites (104) 104
h-3 idazoxan (101) 101
radioligand assay (100) 100
dioxins - pharmacology (98) 98
alpha-2-adrenoceptors (97) 97
receptors, drug - drug effects (97) 97
kinetics (96) 96
receptors, adrenergic, alpha-2 - physiology (94) 94
psychiatry (93) 93
cerebral cortex - metabolism (91) 91
drug interactions (91) 91
imidazoles - metabolism (88) 88
time factors (85) 85
alpha-adrenoceptors (83) 83
tritium (82) 82
brain - drug effects (78) 78
idazoxan - metabolism (78) 78
adrenoceptor (74) 74
neurons - drug effects (74) 74
research article (73) 73
adult (66) 66
behavior, animal - drug effects (66) 66
microdialysis (65) 65
muscle contraction - drug effects (65) 65
norepinephrine - physiology (65) 65
ligands (63) 63
ventrolateral medulla (63) 63
agmatine (62) 62
rilmenidine (62) 62
guinea pigs (61) 61
release (61) 61
inhibition (60) 60
locus coeruleus (60) 60
yohimbine - metabolism (60) 60
cerebral cortex - drug effects (59) 59
imidazoline (59) 59
injections, intraventricular (59) 59
dogs (58) 58
phenylephrine - pharmacology (58) 58
motor activity - drug effects (57) 57
noradrenaline release (57) 57
propranolol - pharmacology (57) 57
benzofurans - pharmacology (56) 56
physiology (55) 55
antihypertensive agents - pharmacology (54) 54
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Behavioural Pharmacology, ISSN 0955-8810, 10/2015, Volume 26, Issue 7 - Special Issue Pharmacological Approaches To The Study Of Social Behaviour - Part 2: Social Modulation Of Drug Effects, pp. 681 - 690
Journal Article
Journal Article
Psychopharmacology, ISSN 0033-3158, 8/2016, Volume 233, Issue 15, pp. 2955 - 2971
Fas-associated death domain (FADD) is an adaptor of death receptors that can also induce anti-apoptotic actions through its phosphorylated form (p-FADD).... 
Neuroplasticity | Neuroprotection | Neurosciences | Biomedicine | FADD and p-FADD | Forced swim test | Anti-depressant drugs | Pharmacology/Toxicology | Psychiatry | Electroconvulsive shock | PRESYNAPTIC AUTORECEPTORS | NEUROTRANSMITTER RELEASE | PSYCHIATRY | ANTIDEPRESSANT TREATMENT | ADRENERGIC-RECEPTOR | MAJOR DEPRESSION | SUICIDE VICTIMS | NEUROSCIENCES | PREFRONTAL CORTEX | MONOAMINE-OXIDASE INHIBITORS | PHARMACOLOGY & PHARMACY | GAMMA-AMINOBUTYRIC-ACID | DEATH DOMAIN PROTEIN | Phosphoproteins - drug effects | Phenelzine - pharmacology | Autoreceptors - metabolism | Clorgyline - pharmacology | Male | Adrenergic alpha-Antagonists - pharmacology | Phosphoproteins - metabolism | Cerebral Cortex - metabolism | Idazoxan - pharmacology | Mianserin - analogs & derivatives | Mianserin - pharmacology | Desipramine - pharmacology | Fluoxetine - analogs & derivatives | Mirtazapine | Antidepressive Agents - pharmacology | Cerebral Cortex - drug effects | Phosphorylation - drug effects | RNA-Binding Proteins - antagonists & inhibitors | Fluoxetine - pharmacology | Idazoxan - analogs & derivatives | Monoamine Oxidase Inhibitors - pharmacology | Fas-Associated Death Domain Protein - drug effects | Norepinephrine Plasma Membrane Transport Proteins - antagonists & inhibitors | Fas-Associated Death Domain Protein - metabolism | Rats | Excitatory Amino Acid Antagonists - pharmacology | Blotting, Western | Brain - drug effects | Animals | CASP8 and FADD-Like Apoptosis Regulating Protein | Thiazoles - pharmacology | Ketamine - pharmacology | Electroshock | Apoptosis | Indans - pharmacology | Pharmacology, Experimental | Antidepressants | Desipramine | Fluoxetine | Psychopharmacology | Dosage and administration | Research | Proteins | Brain | Rodents
Journal Article
Psychopharmacology, ISSN 0033-3158, 2014, Volume 231, Issue 8, pp. 1503 - 1515
Rationale Social play behavior is a characteristic form of social behavior displayed by juvenile and adolescent mammals. This social play behavior is highly... 
Adolescence | Neurosciences | Biomedicine | Amphetamine | Dopamine | Serotonin | Alpha-2 adrenoceptor | Social play | Cocaine | Pharmacology/Toxicology | Psychiatry | Noradrenaline | SUBSTANCE USE | DOPAMINE RELEASE | PSYCHIATRY | ADOLESCENT RATS | LOCOMOTOR-ACTIVITY | ADULT-RATS | JUVENILE RATS | PSYCHOMOTOR STIMULANTS | NEUROSCIENCES | PHARMACOLOGY & PHARMACY | RATTUS-NORVEGICUS | MODULATION | BRAIN | Motor Activity - physiology | Rats, Wistar | Motor Activity - drug effects | Male | Behavior, Animal | Dose-Response Relationship, Drug | Idazoxan - pharmacology | Exploratory Behavior - physiology | Social Behavior | Atomoxetine Hydrochloride | Exploratory Behavior - drug effects | Flupenthixol - pharmacology | Fluoxetine - pharmacology | Idazoxan - analogs & derivatives | Dopamine Uptake Inhibitors - pharmacology | Play and Playthings | Amphetamine - pharmacology | Serotonin Antagonists - pharmacology | Adrenergic Agents - pharmacology | Adrenergic alpha-2 Receptor Antagonists - pharmacology | Piperazines - pharmacology | Cocaine - pharmacology | Animals | Dopamine Antagonists - pharmacology | Adrenergic Uptake Inhibitors - pharmacology | Propylamines - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Complications and side effects | Amphetamines | Physiological aspects | Dosage and administration | Research | Social behavior in animals | Animal behavior | Rodents | Psychopharmacology
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2007, Volume 104, Issue 24, pp. 9982 - 9987
Arginine contains the guanidinium group and thus has structural similarity to ligands of imidazoline and α-2 adrenoceptors (α-2 AR). Therefore, we investigated... 
Cell culture techniques | Signal transduction | Receptors | Imidazolines | Fluorescence | Agonists | Ligands | Toxins | Endothelial cells | Whooping cough | Calcium | Agmatine | Rauwolscine | rauwolscine | calcium | DEPENDENT VASODILATION | VASCULAR RELAXATION | MULTIDISCIPLINARY SCIENCES | agmatine | RELAXING FACTOR | PORCINE CORONARY-ARTERIES | RELEASE | SYNTHASE | SMOOTH-MUSCLE | CHOLESTEROL-FED RABBITS | S-NITROSOTHIOLS | Endothelium, Vascular - cytology | Aniline Compounds | Humans | Receptors, Adrenergic, alpha-2 - metabolism | Culture Media, Serum-Free | Adrenergic alpha-Antagonists - pharmacology | Calcium - analysis | Agmatine - pharmacology | Virulence Factors, Bordetella - pharmacology | Type C Phospholipases - antagonists & inhibitors | Yohimbine - pharmacology | Dose-Response Relationship, Drug | Idazoxan - pharmacology | Arginine - antagonists & inhibitors | Estrenes - pharmacology | Pyrrolidinones - pharmacology | Agmatine - chemistry | Dexmedetomidine - pharmacology | Molecular Structure | Cell Culture Techniques | Nitric Oxide Synthase Type III - metabolism | Umbilical Veins - cytology | Nitrates - analysis | NG-Nitroarginine Methyl Ester - pharmacology | Nitric Oxide - biosynthesis | Nifedipine - pharmacology | Idazoxan - chemistry | Endothelial Cells - metabolism | Nitric Oxide - antagonists & inhibitors | Cells, Cultured | Imidazolines - pharmacology | Calcium Channel Blockers - pharmacology | Enzyme Activation - drug effects | Arginine - chemistry | Xanthenes | Endothelial Cells - cytology | Arginine - pharmacology | Lipopolysaccharides - pharmacology | Second Messenger Systems - physiology | Nitrites - analysis | Endothelial Cells - enzymology | Fluorescent Dyes | Biological Sciences
Journal Article
Journal Article
EUROPEAN JOURNAL OF PHARMACOLOGY, ISSN 0014-2999, 07/2005, Volume 517, Issue 1-2, pp. 51 - 58
The aim of the present study was to investigate the modulation of locus coeruleus neurons by the selective serotonin (5-ITT) reuptake inhibitor citalopram... 
BRAIN-SLICES | antidepressant | 5-HT2A RECEPTOR | MAJOR DEPRESSION | ANTIDEPRESSANT DRUGS | SEROTONIN REUPTAKE INHIBITORS | idazoxan | alpha-adrenoceptor | RECEPTOR ANTAGONISM | firing activity | PHARMACOLOGY & PHARMACY | 5-HT receptor | noradrenaline | NORADRENERGIC NEURONS | MEDIATED INHIBITION | Norepinephrine - pharmacology | Citalopram - pharmacology | Methiothepin - pharmacology | Amphetamines - pharmacology | Locus Coeruleus - drug effects | Male | Adrenergic alpha-Antagonists - pharmacology | Serotonin - pharmacology | Serotonin Receptor Agonists - pharmacology | Dose-Response Relationship, Drug | Idazoxan - pharmacology | Quinoxalines - pharmacology | Adrenergic alpha-2 Receptor Agonists | Locus Coeruleus - cytology | Piperidines - pharmacology | Neurons - physiology | Neurons - drug effects | Receptors, Adrenergic, alpha-2 - physiology | Action Potentials - drug effects | Oxazines - pharmacology | Rats | Thiophenes - pharmacology | Locus Coeruleus - physiology | Brimonidine Tartrate | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacology | Receptors, Opioid, mu - antagonists & inhibitors | Serotonin Antagonists - pharmacology | Piperazines - pharmacology | Rats, Sprague-Dawley | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Animals | Naloxone - pharmacology | Narcotic Antagonists - pharmacology | Duloxetine Hydrochloride | Adrenergic alpha-Agonists - pharmacology | Pyridines - pharmacology | Adrenergic alpha-2 Receptor Antagonists | In Vitro Techniques | Serotonin Uptake Inhibitors - pharmacology
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 2/2013, Volume 27, Issue 2, pp. 213 - 221
Previous studies have shown that drugs which block the reuptake of catecholamine neurotransmitters improve impulse control in diseases such as attention... 
monoamine reuptake | ADHD | serotonin | rat | impulsivity | attention | dopamine | Noradrenaline | 5-choice serial reaction time task | NORADRENALINE REUPTAKE INHIBITOR | PSYCHIATRY | NEUROSCIENCES | PREFRONTAL CORTEX | CLINICAL NEUROLOGY | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | BORDERLINE PERSONALITY-DISORDER | RAT FRONTAL-CORTEX | NOREPINEPHRINE TRANSPORTER | IN-VIVO | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | EXTRACELLULAR CONCENTRATIONS | FUNCTIONAL NEUROCHEMISTRY | Fluoxetine - pharmacology | Norepinephrine - pharmacology | Choice Behavior - drug effects | Rats | Acetamides - pharmacology | Male | Impulsive Behavior - physiopathology | Adrenergic alpha-2 Receptor Antagonists - pharmacology | Idazoxan - pharmacology | Venlafaxine Hydrochloride | Animals | Cyclobutanes - pharmacology | Reaction Time - drug effects | Behavior, Animal - drug effects | Antidepressive Agents - pharmacology | Bupropion - pharmacology | Hypnotics and Sedatives - pharmacology | Cyclohexanols - pharmacology | Paroxetine - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Serotonin uptake inhibitors | Neurotransmitters | Dosage and administration | Research | Monoamines | Impulse | Drugs | Dopamine | Fluoxetine | Attention deficit hyperactivity disorder | impulsive behavior | Catecholamines | Data processing | Suicide | Reaction time task | sibutramine | paroxetine | Antidepressants | Venlafaxine | Norepinephrine | bupropion | monoamines
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 09/2004, Volume 24, Issue 35, pp. 7745 - 7753
Norepinephrine (NE) plays a complex role in the behavioral state-dependent regulation of sensory processing. However, the role of forebrain NE action in... 
Forebrain | Song system | Norepinephrine | Auditory | Behavioral state | Arousal | norepinephrine | MALE ZEBRA FINCHES | JAPANESE QUAIL | song system | VOCAL CONTROL | LOCUS COERULEUS NEURONS | CORTICAL NEURONAL RESPONSES | PUTATIVE NEUROTRANSMITTERS | ADRENERGIC-RECEPTORS | NEUROSCIENCES | CEREBRAL-CORTEX | behavioral state | auditory | MOVING VISUAL-STIMULI | forebrain | arousal | Norepinephrine - pharmacology | Receptors, Adrenergic, beta-2 - physiology | Norepinephrine - physiology | Adrenergic Fibers - physiology | Male | Prosencephalon - physiology | Adrenergic alpha-Antagonists - pharmacology | Adrenergic Fibers - drug effects | Receptors, Adrenergic, beta-2 - drug effects | Auditory Perception - physiology | Finches - physiology | Prosencephalon - drug effects | Yohimbine - pharmacology | Dose-Response Relationship, Drug | Idazoxan - pharmacology | Receptors, Adrenergic, alpha-2 - drug effects | Adrenergic beta-Antagonists - pharmacology | Phenylephrine - pharmacology | Clonidine - pharmacology | Vocalization, Animal - drug effects | Receptors, Adrenergic, alpha-2 - physiology | Receptors, Adrenergic, alpha-1 - physiology | Oxathiins - pharmacology | Receptors, Adrenergic, alpha-1 - drug effects | Auditory Perception - drug effects | Adrenergic beta-Agonists - pharmacology | Vocalization, Animal - physiology | Imidazoles - pharmacology | Guanabenz - pharmacology | Arousal - physiology | Animals | Isoproterenol - pharmacology | Adrenergic alpha-Agonists - pharmacology | Propanolamines - pharmacology | Behavioral | Cognitive | Systems
Journal Article
Journal Article